Clinical Trial Update: Efficacy of a Combination of Amlodipine/Valsartan on 24H Blood Pressure Control With One Nocturnal or Diurnal Intake a Day [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated the efficacy of once-daily amlodipine/valsartan for 24-hour blood pressure control, comparing nocturnal versus diurnal dosing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Exforge (valsartan; amlodipine)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Hypertension | Phase 4 | Status: COMPLETED | Results posted: 2011-01-06